Magnesium in Diabetic Patients
Phase 2
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2019/12/022496
- Lead Sponsor
- Dr Sakthi balan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Male or female Type 2 DM patients treated with oral hypoglycemic agents, in the age group of 18-60 years.
2.HbA1C levels of the patients should be between 6.5 to 7.0% in the last 3 months.
3.Patients having low serum magnesium levels < 1.46 mg/dL21.
4.Patient should have not participated in any other study during the past 3 months.
Exclusion Criteria
1.Patients who are having other conditions contraindicating for magnesium supplementation.
2.Patients who are alcoholic, suffering from chronic diarrhoea and on treatment with diuretics within 4 weeks before study initiation.
3.Pregnant and lactating women.
4.Patients who are unable to sign informed consent or unable to comply with study procedure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the glycemic status (FBS, PPBS, HbA1c) among patients treated with oral hypoglycemic agents alone and oral hypoglycemic agents with magnesium glycinate supplementTimepoint: 4,8 and 12 weeks
- Secondary Outcome Measures
Name Time Method well being assessment by questionnaire.Timepoint: baseline and 12 weeks